Skip to main content

Table 3 Undiagnosed patients: reasons for referral and diagnosis

From: Clouds over IMD? Perspectives for inherited metabolic diseases in adults from a retrospective cohort study in two Swiss adult metabolic clinics

ID

Reason for referral

IEM diagnosis

OMIM#

1

Myopathy, ptosis

Mitochondrial disease (CPEO)

609,286

2

Epilepsy, ophthalmoplegia, ptosis

Mitochondriopathy disease (ARPEO)

258,450

3

Myopathy, arthralgia, cognitive delay

Myoadenylate deaminase deficiency

615,511

4

Myopathy, ovary insufficiency, cognitive decline, palpebral ptosis

Mitochondrial disease (ovario leucodystrophy related to AARS2 variant)

615,889

5

Myopathy, respiratory insufficiency

Heterozygous for Pompe late-onset disease (2nd variant not found)

232,300

6

Myopathy, respiratory insufficiency

Pompe late-onset disease

232,300

7

Myopathy, ophthalmoplegia, ptosis

Mitochondrial disease (CPEO)

609,286

8

Pulmonary embolism

Homocystinuria due to CBS deficiency

236,200

9

Intestinal ischemic thrombosis, pulmonary embolism

Homocystinuria due to CBS deficiency

236,200

10

Myopathy, ptosis

Mitochondrial disease (KSS)

530,000

11

Biochemical hypermethioninemia, cognitive delay

Methionine adenosyltransferase I/III deficiency

250,850

12

Progressive myelopathy

X-linked AMN

300,100

13

Splenomegaly, liver cirrhosis, bone lesions

Niemann-Pick type B

607,616

14

Hypoglycemia, hyperammoniemia

HI/HA syndrome

606,762

15

Positive FHx for OTC

OTC deficiency

311,250

16

Positive FHx for CBS deficiency

Homocystinuria due to CBS deficiency

236,200

17

Positive FHx for CBS deficiency

Homocystinuria due to CBS deficiency

236,200

18

Positive FHx for CBS deficiency

Homocystinuria due to CBS deficiency

236,200

19

Positive FHx for CBS deficiency

Homocystinuria due to CBS deficiency

236,200

ID

Reason for referral

Other Genetic diagnosis

 

20

Spastic paraparesis, cognitive delay

Spastic paraparesis related to SPG11 variant

604,360

21

Cerebral calcification, leukoencephalopathy

Nasu-Hakola syndrome (PLOSL)

618,193

22

Peripheric weakness, ataxia, ophthalmoplegia

Autosomal dominant spinocerebellar ataxia 5

600,224

23

Familial neuropathy, muscle weakness

Charcot-Marie Tooth related to LRSAM1 variant

614,436

24

Cognitive decline, peripheric neuropathy, polyglucosan bodies

Charcot-Marie Tooth related to HARS1 variant

616,625

ID

Reason for referral

Possibly related polymorphisms

 

25

Mild elevation of homocysteine

MTHFR polymorphism (compound heterozygous)

NA

26

Mild elevation of homocysteine, venous thrombosis

MTHFR polymorphism (compound heterozygous)

NA

27

Recurrent pregnancy loss

MTHFR polymorphism (compound heterozygous)

NA

  1. Abbreviations: ARPEO: autosomal recessive progressive external ophalmoplegia; AMN, adrenomyeloneuropathy; CPEO: chronic progressive external ophthalmoplegia; CBS: cystathionine-β synthase deficiency; FHx: family history; HI/HA, hyperinsulinism/hyperammoniemia; ID; identity number, KSS: Kearns-Sayre Syndrome; MTHFR, methylenetetrahydrofolate reductase; NA: not applicable; OMIM: online mendelian inheritance in man; OTC, ornithine transcarbamylase; PLOSL, polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy; X-ALD, X-linked adrenoleucodystrophy